We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$296B
AUM Growth
+$22.5B
Cap. Flow
+$7.07B
Cap. Flow %
2.39%
Top 10 Hldgs %
14.04%
Holding
10,482
New
945
Increased
3,995
Reduced
3,457
Closed
1,659

Sector Composition

Rank Sector Weight
1 Technology 13.25%
2 Financials 6.72%
3 Healthcare 6.58%
4 Consumer Discretionary 5.35%
5 Industrials 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAYA icon
8626
Erayak Power Solution Group
RAYA
$2.48M
0
EZRAW
8627
DELISTED
Reliance Global Series A Warrants
EZRAW
$18 ﹤0.01%
+161
New +$19
VSEEW
8628
VSee Health Warrant
VSEEW
$248K
$18 ﹤0.01%
+280
New +$23
AVGR
8629
DELISTED
Avinger, Inc. Common Stock
AVGR
$18 ﹤0.01%
2
-137
-99% -$1.23K
ADOCR
8630
DELISTED
Edoc Acquisition Corp. Right
ADOCR
$18 ﹤0.01%
142
-558
-80% -$85
BNRG icon
8631
Brenmiller Energy
BNRG
$1.18M
-1
Closed -$1.87K
NEPH icon
8632
Nephros
NEPH
$36.8M
$17 ﹤0.01%
11
-226
-95% -$334
PSIL icon
8633
AdvisorShares Psychedelics ETF
PSIL
$48.9M
$17 ﹤0.01%
1
-21
-95% -$376
TISI icon
8634
Team
TISI
$79.5M
$17 ﹤0.01%
2
-528
-100% -$3.06K
YCBD icon
8635
cbdMD
YCBD
$5.32M
$17 ﹤0.01%
2
+1
+100% +$26
TRVN
8636
DELISTED
Trevena, Inc.
TRVN
$17 ﹤0.01%
1
-622
-100% -$15.2K
CTOS.WS
8637
DELISTED
Custom Truck One Source, Inc. Warrants, exerciseable for Common Stock
CTOS.WS
$17 ﹤0.01%
+69
New +$19
ACONW icon
8638
Aclarion Warrant
ACONW
$16 ﹤0.01%
200
-2,097
-91% -$193
CMMB
8639
Chemomab Therapeutics
CMMB
$11.4M
$16 ﹤0.01%
3
-100
-97% -$631
MTUL icon
8640
ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN
MTUL
$15.6M
$16 ﹤0.01%
1
-10,879
-100% -$168K
XELAP
8641
DELISTED
Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock
XELAP
$16 ﹤0.01%
4
-160
-98% -$340
ACAHW
8642
DELISTED
Atlantic Coastal Acquisition Corp. Warrant
ACAHW
$16 ﹤0.01%
+687
New +$34
AMPE
8643
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$16 ﹤0.01%
3
-671
-100% -$3.29K
ATEK.WS
8644
DELISTED
Athena Technology Acquisition Corp. II Redeemable Warrants
ATEK.WS
$15 ﹤0.01%
+337
New +$30
FUNC icon
8645
First United
FUNC
$285M
$14 ﹤0.01%
1
-1,165
-100% -$17.2K
HSCSW icon
8646
HeartSciences Inc Warrant
HSCSW
$14 ﹤0.01%
90
-2,503
-97% -$448
NEXI
8647
DELISTED
NexImmune, Inc. Common Stock
NEXI
$14 ﹤0.01%
2
CADL icon
8648
Candel Therapeutics
CADL
$733M
$13 ﹤0.01%
10
BNBX
8649
DELISTED
BNB PLUS CORP
BNBX
-1
Closed -$17.4K
FORLW
8650
DELISTED
Four Leaf Acquisition Corp Warrants
FORLW
$12 ﹤0.01%
+98
New +$10

Similar funds

UBS Group's Q2 2023 Portfolio in Review

As of Q2 2023, UBS Group held 10,482 positions worth $296B, up 8.2% from $274B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q2 2023 filing shows 945 new, 3,995 increased, 3,457 reduced and 1,659 closed positions. Its largest new stake was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M. The largest sale was UBS Group, an estimated $3.79B.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2023 buy was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M.
  • UBS Group added most to State Street Financial Select Sector SPDR ETF in Q2 2023, an estimated $456M increase.
  • UBS Group's biggest Q2 2023 reduction was UBS Group, cutting an estimated $3.79B.
  • UBS Group fully exited DCP Midstream, LP in Q2 2023, selling an estimated $148M.
  • UBS Group's ten largest holdings make up 14% of its $296B portfolio in Q2 2023.
  • UBS Group opened 945 new positions and closed 1,659 in Q2 2023.
  • UBS Group's portfolio value rose 8.2% quarter-over-quarter to $296B.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.